Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Latent Epstein-Barr virus can inhibit apoptosis in B cells by blocking the induction of NOXA expression.

Yee J, White RE, Anderton E, Allday MJ.

PLoS One. 2011;6(12):e28506. doi: 10.1371/journal.pone.0028506. Epub 2011 Dec 9.

2.

Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.

Niedobitek G, Agathanggelou A, Rowe M, Jones EL, Jones DB, Turyaguma P, Oryema J, Wright DH, Young LS.

Blood. 1995 Jul 15;86(2):659-65.

3.

Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.

Paschos K, Smith P, Anderton E, Middeldorp JM, White RE, Allday MJ.

PLoS Pathog. 2009 Jun;5(6):e1000492. doi: 10.1371/journal.ppat.1000492. Epub 2009 Jun 26.

4.

Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.

Kelly GL, Milner AE, Baldwin GS, Bell AI, Rickinson AB.

Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14935-40. Epub 2006 Sep 25.

5.

hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.

Giunco S, Dolcetti R, Keppel S, Celeghin A, Indraccolo S, Dal Col J, Mastorci K, De Rossi A.

Clin Cancer Res. 2013 Apr 15;19(8):2036-47. doi: 10.1158/1078-0432.CCR-12-2537. Epub 2013 Feb 26.

6.

Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.

Campion EM, Hakimjavadi R, Loughran ST, Phelan S, Smith SM, D'Souza BN, Tierney RJ, Bell AI, Cahill PA, Walls D.

J Virol. 2014 May;88(9):5001-13. doi: 10.1128/JVI.03642-13. Epub 2014 Feb 19.

7.

Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.

Watanabe A, Maruo S, Ito T, Ito M, Katsumura KR, Takada K.

J Virol. 2010 Mar;84(6):2893-901. doi: 10.1128/JVI.01616-09. Epub 2009 Dec 30.

8.

Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.

Wang A, Welch R, Zhao B, Ta T, Keleş S, Johannsen E.

J Virol. 2015 Dec 30;90(6):2906-19. doi: 10.1128/JVI.02737-15.

9.

Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.

Leao M, Anderton E, Wade M, Meekings K, Allday MJ.

J Virol. 2007 Jan;81(1):248-60. Epub 2006 Oct 11.

10.

Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.

Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC.

Arch Virol. 2004 Feb;149(2):289-302. Epub 2003 Nov 4.

PMID:
14745596
11.

An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.

Kelly GL, Long HM, Stylianou J, Thomas WA, Leese A, Bell AI, Bornkamm GW, Mautner J, Rickinson AB, Rowe M.

PLoS Pathog. 2009 Mar;5(3):e1000341. doi: 10.1371/journal.ppat.1000341. Epub 2009 Mar 13.

12.

Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.

Schmidt SC, Jiang S, Zhou H, Willox B, Holthaus AM, Kharchenko PV, Johannsen EC, Kieff E, Zhao B.

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):554-9. doi: 10.1073/pnas.1422580112. Epub 2014 Dec 24.

14.

Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells.

Fagard R, Mouas H, Dusanter-Fourt I, Devillers C, Bissières P, Martin A, Lenoir G, VanTan H, Feuillard J, Raphaël M.

Oncogene. 2002 Jul 4;21(29):4473-80.

15.

Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.

Skalska L, White RE, Parker GA, Turro E, Sinclair AJ, Paschos K, Allday MJ.

PLoS Pathog. 2013 Feb;9(2):e1003187. doi: 10.1371/journal.ppat.1003187. Epub 2013 Feb 21. Erratum in: PLoS Pathog. 2013 Mar; 9(3): doi:10.1371/annotation/2c4b89c1-6d4a-4bf3-9467-9367227d7e74. Turro, Ernest [added].

16.

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.

Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB.

J Virol. 1992 Jan;66(1):122-31.

17.

Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.

De Leo A, Arena G, Stecca C, Raciti M, Mattia E.

Mol Cancer Res. 2011 Oct;9(10):1346-55. doi: 10.1158/1541-7786.MCR-11-0145. Epub 2011 Aug 19.

18.

An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1.

Skinner CM, Ivanov NS, Barr SA, Chen Y, Skalsky RL.

J Virol. 2017 Oct 13;91(21). pii: e00530-17. doi: 10.1128/JVI.00530-17. Print 2017 Nov 1.

19.

The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells.

Pratt ZL, Zhang J, Sugden B.

J Virol. 2012 Apr;86(8):4380-93. doi: 10.1128/JVI.06966-11. Epub 2012 Feb 8.

20.

Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.

Anderton E, Yee J, Smith P, Crook T, White RE, Allday MJ.

Oncogene. 2008 Jan 17;27(4):421-33. Epub 2007 Jul 23.

PMID:
17653091

Supplemental Content

Support Center